We spoke to Professor Lou Chesler and Dr Lynley Marshall about the innovative studies that are aiming to make children’s cancer treatment more tailored.
Looking at the latest results from the BEST3 trial, analysing the ‘sponge-on-a-string’ test to detect oesophageal cancer earlier.
We’re having to scale down our work to reflect our new situation, but our ambition remains the same, writes our chief executive, Michelle Mitchell.
We caught up with a number of researchers about how COVID-19 has impacted their work, and what the next few months looks like for them.
Professor Richard Gilbertson talks about the impact of COVID-19 on research at the Cancer Research UK Cambridge Centre.
Our scientists have been hunting for patterns that could reveals clues about metabolism and cancer.
Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.
We look at some of the work being done to keep people with cancer on clinical trials during the coronavirus pandemic.